ClearanceBrief
510(k) K221605 · DJG Enzyme Immunoassay, Opiates

Emit® II Plus Buprenorphine Assay

ApplicantSiemens Healthcare Diagnostics, Inc., Newark DE, US
DecisionSubstantially Equivalent, Jul 25, 2023
ReceivedJun 2, 2022
TypeTraditional
FDA recordOpen on fda.gov

Recalls that name K221605

No recall in the FDA data names this 510(k).

Links come from the 510(k) numbers listed on each FDA recall record. We don't infer predicate chains.